Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations

Free article

Editorial

Yasushi Yatabe et al. J Thorac Oncol. 2012 May.

Free article

. 2012 May;7(5):775-6.

doi: 10.1097/JTO.0b013e318251980b.

No abstract available

Comment in

A novel EGFR mutation in exon 19 showed stable disease after TKI treatment.
van der Wekken AJ, Stigt JA, A't Hart N. van der Wekken AJ, et al. J Thorac Oncol. 2012 Aug;7(8):e8. doi: 10.1097/JTO.0b013e31825ccae8. J Thorac Oncol. 2012. PMID: 22797155 No abstract available.
A novel EGFR mutation in exon 18 with high sensitivity to EGFR TKI treatment with reduced dose.
Brandão EP, Pantarotto MG, Cruz M. Brandão EP, et al. J Thorac Oncol. 2012 Nov;7(11):e32. doi: 10.1097/JTO.0b013e31826d8f66. J Thorac Oncol. 2012. PMID: 23070249 No abstract available.

Rare and novel epidermal growth factor receptor mutations in non-small-cell lung cancer and lack of clinical response to gefitinib in two cases.
Sharma A, Tan TH, Cheetham G, Scott HS, Brown MP. Sharma A, et al. J Thorac Oncol. 2012 May;7(5):941-2. doi: 10.1097/JTO.0b013e31825134ac. J Thorac Oncol. 2012. PMID: 22722798 No abstract available.